Neil Dixon received a 1st class Hons degree in Medicinal Chemistry from the University of Leeds (UK) in 2000 and then undertook in his PhD in Bioorganic Chemistry also at Leeds on “Probing the inhibition of the vacuolar (H⁺)-ATPase: targeting osteoporosis” (2004). After an extended period travel in Latin America he then pursued post-doctoral research in Chemical Biology at the University of Manchester (UK) on the topic re-engineering the molecular recognition properties of regulatory RNAs termed riboswitches, using rational design, high-throughput screening, directed evolution, along with structural and and biophysical characterization (2006-2010).
Neil Dixon previously held a BBSRC David Phillips Fellowship and a BBSRC Enterprise fellow based at the Manchester Institute of Biotechnology(MIB). His research group is focused on developing engineering tools and technologies to enhance the capacity and introduce new capability into biological hosts for biotech and biomed applications. His group currently comprising of 3 post doctoral scientists, 5 PhD students and 2 Research Techniciasn is supported from BBSRC, EPSRC, Innovate UK, Wellcome Trust, Brazilian and Indonesian Governments.